Co-processed Excipients for Pharmaceutical Applications
Continuous manufacturing is a future trend in solid dosage form manufacturing. Yet, it also faces challenges due to limitations in performance of different excipients used. The development and application of co-processed excipients has brought significant improvements to the flowability, compressibility and uniformity problems encountered in continuous manufacturing. Things are getting much easier.
BASF offers a wide range of co-processed excipients for a variety of formulations in direct compression, extended release, and orally disintegrating tablets. The new all-in-one excipient, KollitabTM DC 87 L, is the best choice for direct compression and continuous manufacturing processes. Watch the webinar video to learn more.
Please note: this webinar is conducted in Mandarin